Hélène Labussière‐Wallet

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes et al. · The Lancet Haematology · 2019 · 154 citations · Full text

Medicine, Hematology, Immunology +17

High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation

Lila Gilis, Stéphane Morisset, Geneviève Billaud et al. · Bone Marrow Transplantation · 2014 · 147 citations

Medicine, Hematology, Infectious Diseases +16

Effect of Azithromycin on Airflow Decline–Free Survival After Allogeneic Hematopoietic Stem Cell Transplant

Anne Bergeron, Sylvie Chevret, Angéla Granata et al. · JAMA · 2017 · 119 citations

Medicine, Immunology, Pharmacotherapy +15

Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation

Michaël Philippe, Florence Ranchon, Lila Gilis et al. · Biology of Blood and Marrow Transplantation · 2015 · 79 citations · Full text

Pharmacy, Hematology, Infectious Diseases +14

Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT

Noga Shem‐Tov, Christophe Peczynski, Myriam Labopin et al. · Leukemia · 2019 · 79 citations

Medicine, Hematology, Oncology +12